CN108524739A - A kind of gel agent for treating bedsore - Google Patents

A kind of gel agent for treating bedsore Download PDF

Info

Publication number
CN108524739A
CN108524739A CN201810667331.9A CN201810667331A CN108524739A CN 108524739 A CN108524739 A CN 108524739A CN 201810667331 A CN201810667331 A CN 201810667331A CN 108524739 A CN108524739 A CN 108524739A
Authority
CN
China
Prior art keywords
bedsore
added
hbp
gel
organic nano
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201810667331.9A
Other languages
Chinese (zh)
Inventor
相锐
李晓倩
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
XI'AN IAMTECH POLYMER MATERIAL Ltd
Original Assignee
XI'AN IAMTECH POLYMER MATERIAL Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by XI'AN IAMTECH POLYMER MATERIAL Ltd filed Critical XI'AN IAMTECH POLYMER MATERIAL Ltd
Priority to CN201810667331.9A priority Critical patent/CN108524739A/en
Publication of CN108524739A publication Critical patent/CN108524739A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/738Rosa (rose)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/886Aloeaceae (Aloe family), e.g. aloe vera
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02Local antiseptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention discloses a kind of gel agents for treating bedsore; it is characterized in that; long-acting bactericidal protective barrier can be formed in bed sore surface by treating the gel of bedsore; inhibit the invasion of bacterial fungus; generation that is fundamentally antipruritic and reducing bedsore; the invention efficiently solves that traditional medicament function and effect are poor, and the replacement cycle is short, needs the defect removed necrosis and promoted granulation.

Description

A kind of gel agent for treating bedsore
Technical field
The invention belongs to Field of Drug Discovery, are related to a kind of medicament of clinic treatment bedsore.
Background technology
Bedsore(Also known as pressure sore, pressure ulcer), be cause for some reason ischemic cause local inflammatory response or even Extraneous pathogen invasion generates local infection, and makes tissue necrosis.Bedsore is apt to occur in compression and lacks adipose tissue protection, no flesh At the bone knuckle that pork pies are wrapped up in or muscle layer is relatively thin.Bedsore is still the first complication of patient bedridden in long term so far, tight due to occurring Weight bedsore infects and dead patient ratio in bed crowd is caused to be up to 50%.According to related document report, there are about 60,000 people every year Die of bedsore complication.It is No.1 " killer " that bedsore has become bed patient, should cause the enough attention of medical field.Bedsore is controlled It treating, doctor removes necrosis and promote granulation and the doctor of profession is needed to go to operate based on removing necrosis and promoting granulation, costly, and pain is big, ineffective, because This, the effective medicament for treating bedsore seems increasingly important for patients.
Currently, on the market bedsore paste treatment need remove necrotic tissue and promoting muscle growing, therapeutic effect unobvious, easily repeatedly the defects of. The present invention proposes a kind of quick, long-acting treatment bedsore medicament.The gel that the present invention treats bedsore has long-acting bactericidal characteristic, Antiseptic film can be formed in the surface of a wound of bedsore, the germ-free condition for keeping the surface of a wound lasting reduces intrusion of the bacterium to the surface of a wound, accelerates wound The recovery in face.
Invention content
The purpose of the present invention is to solve the defects of existing band bed sore ointment, and a kind of organic nano HBP proposed is used as and kills The band bed sore ointment of microbial inoculum.
To achieve the goals above, the present invention adopts the following technical scheme that:
A kind of a kind of gel agent for treating bedsore, which is characterized in that preparation method of gel agent that treating bedsore:
(1)Rilanit special and organic nano HBP are weighed according to certain mass ratio, and is thoroughly mixed uniformly, is obtained newborn The organic nano HBP of change;
(2)Certain mass purified water is weighed, is added in carbomer, is stirred, add Sodium Hyaluronate, be sufficiently stirred Uniformly;
(3)It weighs Seabuckthorn Oil, be added in the organic nano HBP being emulsified after Rosa Damascana is mixed evenly, carry out abundant Stirring;
(4)By step(3)Product, be added to step(2)Product in, stir, then add triethanolamine thickening;
(5)Aloe liquid, glycerine and menthol are added to step(4)Product in, stir to get to treatment bedsore Gel.
The technical advantage of the present invention:
Patent of the present invention not only solves the problems, such as that bedsore needs are removed necrosis and promoted granulation, while also efficiently solving general bedsore Drug replacement cycle short problem.
Specific implementation mode
Embodiment 1
(1)Rilanit special 60.0g and organic nano HBP41.0g are weighed, and is thoroughly mixed uniformly, is emulsified Organic nano HBP;
(2)Certain mass purified water 510.0g is weighed, 60.0g in carbomer is added, stirs, adds hyaluronic acid Sodium 9.0g, stirs;
(3)Weigh Seabuckthorn Oil 1.5g, Rosa Damascana 15.0g is added to after being mixed evenly in the organic nano HBP being emulsified, It is sufficiently stirred;
(4)By step(3)Product, be added to step(2)Product in, stir, then triethanolamine 2.0g is added to increase It is thick;
(5)Aloe liquid 150.0g, glycerine 150.0g and menthol 1.5g are added to step(4)Product in, be sufficiently stirred It is even to get to treatment bedsore gel.
Embodiment 2
(1)Rilanit special 60.0g and organic nano HBP41.0g are weighed, and is thoroughly mixed uniformly, is emulsified Organic nano HBP;
(2)Certain mass purified water 515.0g is weighed, 60.0g in carbomer is added, stirs, adds hyaluronic acid Sodium 4.0g, stirs;
(3)Weigh Seabuckthorn Oil 2.0g, Rosa Damascana 15.0g is added to after being mixed evenly in the organic nano HBP being emulsified, It is sufficiently stirred;
(4)By step(3)Product, be added to step(2)Product in, stir, then triethanolamine 2.0g is added to increase It is thick;
(5)Aloe liquid 150.0g, glycerine 150.0g and menthol 1.0g are added to step(4)Product in, be sufficiently stirred It is even to get to treatment bedsore gel.
Embodiment 3
(1)Rilanit special 60.0g and organic nano HBP41.0g are weighed, and is thoroughly mixed uniformly, is emulsified Organic nano HBP;
(2)Certain mass purified water 515.0g is weighed, 60.0g in carbomer is added, stirs, adds hyaluronic acid Sodium 6.0g, stirs;
(3)Weigh Seabuckthorn Oil 1.0g, Rosa Damascana 15.0g is added to after being mixed evenly in the organic nano HBP being emulsified, It is sufficiently stirred;
(4)By step(3)Product, be added to step(2)Product in, stir, then triethanolamine 1.0g is added to increase It is thick;
(5)Aloe liquid 160.0g, glycerine 140.0g and menthol 1.0g are added to step(4)Product in, be sufficiently stirred It is even to get to treatment bedsore gel.
The present invention is not limited to the above embodiments, other any to be made under without departing from essence of the present invention and principle Modification, modification, simplified, combination etc., are considered equivalent displacement, are included in protection scope of the present invention.

Claims (2)

1. a kind of gel agent for treating bedsore, it is characterised in that:The medicament is by following component according to certain mass fraction set At:Organic nano HBP 3.0~5.0, carbomer 4.0~6.0, rilanit special 5.0~8.0, purified water 40.0~55.0, three Ethanol amine 0.1~0.2, Seabuckthorn Oil 0.1~0.2, Rosa Damascana 1.0~2.0, aloe liquid 10.0~20.0, menthol 0.1~ 0.2, glycerine 10.0~15.0, Sodium Hyaluronate 0.3~1.0.
2. according to described in claim 1, which is characterized in that a kind of preparation method of gel that treating bedsore:
(1)Rilanit special and organic nano HBP are weighed according to certain mass ratio, and is thoroughly mixed uniformly, is obtained newborn The organic nano HBP of change;
(2)Certain mass purified water is weighed, is added in carbomer, is stirred, add Sodium Hyaluronate, be sufficiently stirred Uniformly;
(3)It weighs Seabuckthorn Oil, be added in the organic nano HBP being emulsified after Rosa Damascana is mixed evenly, carry out abundant Stirring;
(4)By step(3)Product, be added to step(2)Product in, stir, then add triethanolamine thickening;
(5)Aloe liquid, glycerine and menthol are added to step(4)Product in, stir to get to treatment bedsore Gel.
CN201810667331.9A 2018-06-26 2018-06-26 A kind of gel agent for treating bedsore Pending CN108524739A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810667331.9A CN108524739A (en) 2018-06-26 2018-06-26 A kind of gel agent for treating bedsore

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810667331.9A CN108524739A (en) 2018-06-26 2018-06-26 A kind of gel agent for treating bedsore

Publications (1)

Publication Number Publication Date
CN108524739A true CN108524739A (en) 2018-09-14

Family

ID=63486995

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810667331.9A Pending CN108524739A (en) 2018-06-26 2018-06-26 A kind of gel agent for treating bedsore

Country Status (1)

Country Link
CN (1) CN108524739A (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101757075A (en) * 2009-10-30 2010-06-30 吕晓梅 Medicament of Chinese medicine for treating burn and bedsore and preparation method thereof
CN102100650A (en) * 2011-01-28 2011-06-22 武汉耦合医学科技有限责任公司 Gel medical supply for preventing bedsore and preparation method thereof
CN105055713A (en) * 2015-09-16 2015-11-18 凌海市展望生物科技有限公司 Drug composition for preventing or curing bedsore and preparation method thereof
CN106421392A (en) * 2016-11-02 2017-02-22 福元药业股份有限公司 Traditional Chinese medicinal gel for treating bedsore and preparation method of traditional Chinese medicinal gel
CN106619485A (en) * 2015-11-02 2017-05-10 西安艾姆高分子材料有限公司 Organic nanometer ointment for quickly restoring burn, scald and wound

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101757075A (en) * 2009-10-30 2010-06-30 吕晓梅 Medicament of Chinese medicine for treating burn and bedsore and preparation method thereof
CN102100650A (en) * 2011-01-28 2011-06-22 武汉耦合医学科技有限责任公司 Gel medical supply for preventing bedsore and preparation method thereof
CN105055713A (en) * 2015-09-16 2015-11-18 凌海市展望生物科技有限公司 Drug composition for preventing or curing bedsore and preparation method thereof
CN106619485A (en) * 2015-11-02 2017-05-10 西安艾姆高分子材料有限公司 Organic nanometer ointment for quickly restoring burn, scald and wound
CN106421392A (en) * 2016-11-02 2017-02-22 福元药业股份有限公司 Traditional Chinese medicinal gel for treating bedsore and preparation method of traditional Chinese medicinal gel

Similar Documents

Publication Publication Date Title
CN1679745A (en) External-applied medicine for treating burn, valnus and local tumor inflammation
CN103385926A (en) Antibiosis gel for curing cervical and vaginal diseases of gynaecology
CN1943600A (en) Medicinal composition containing American cockroach and its ethanol extract and new use
JPH08505388A (en) Hyaluronic acid-urea pharmaceutical composition and use thereof
CN102247616A (en) Gel preparation used for treating gynecological disease of cervical erosion and the like and preparation technology thereof
CN110038039A (en) A kind of bacteriostatic gel and preparation method
CN108524739A (en) A kind of gel agent for treating bedsore
CN101401890B (en) External use medicament capable of effectively treating wound surface infection
CN1268357C (en) Medicine composition for treating furuncle, abscess, carbuncle, furuncle, burn and scald
Cady et al. Treatment of chronic ulcers with chlorophyll: review of a series of fifty cases
CN104873574A (en) Ointment for relieving pain
CN102335462A (en) Nano iodine-chitosan cervical disease treating membrane agent and preparation method of membrane
CN106237029B (en) A kind of aloe antibiotic gel and preparation method thereof
CN104906132B (en) A kind of plaster for preventing and treating lamb stomatitis
WO2018161890A1 (en) Application of berberine in preparing drug for treating acute soft tissue injury
CN108635362B (en) Pharmaceutical composition for treating diabetic foot
CN102552405B (en) Method for preparing medicinal composition for perianal anaesthetic analgesia of postoperation
CN1293885C (en) High-permeability burn treating prepn
RU2356556C1 (en) Medicine for treatment of mammary glands inflammation and traumas in cows
CN101513478B (en) External application ointment for treating III stage angiitis
CN104906131B (en) A kind of preparation method preventing and treating lamb stomatitis plaster
CN1056774C (en) Keyoulin sterilizing bactericide
CN110420199A (en) It is a kind of for wound healing and the water gel of cosmetics and its preparation method and application
CN114788838A (en) Pain-relieving gel and preparation method thereof
CN105477095A (en) External traditional Chinese medicine ointment for recovery from burns and scalds

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20180914